Analysts Set MedEquities Realty Trust Inc. (MRT) Price Target at $12.67

MedEquities Realty Trust Inc. (NYSE:MRT) has received an average recommendation of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $12.67.

Separately, Zacks Investment Research cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 3rd.

ILLEGAL ACTIVITY NOTICE: “Analysts Set MedEquities Realty Trust Inc. (MRT) Price Target at $12.67” was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2017/08/11/medequities-realty-trust-inc-mrt-receives-12-67-average-target-price-from-analysts-updated-updated-updated.html.

Shares of MedEquities Realty Trust (NYSE:MRT) traded up 0.17% on Friday, hitting $11.72. The company’s stock had a trading volume of 135,813 shares. The stock’s 50 day moving average is $12.32 and its 200-day moving average is $11.72. MedEquities Realty Trust has a 52 week low of $10.28 and a 52 week high of $13.06. The company has a market cap of $372.17 million and a price-to-earnings ratio of 35.62.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 30th. Shareholders of record on Wednesday, August 16th will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.17%. The ex-dividend date is Monday, August 14th. MedEquities Realty Trust’s dividend payout ratio (DPR) is currently 240.00%.

Several large investors have recently modified their holdings of MRT. Russell Investments Group Ltd. bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $3,383,000. State Street Corp bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $2,938,000. Allianz Asset Management AG bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $125,000. GSA Capital Partners LLP bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $229,000. Finally, Metropolitan Life Insurance Co. NY bought a new stake in shares of MedEquities Realty Trust during the fourth quarter worth about $297,000. 95.18% of the stock is owned by institutional investors.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

What are top analysts saying about MedEquities Realty Trust Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MedEquities Realty Trust Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit